We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Steven Madden
SHOO
$3.22B
| $1.29M | ﹤0.01% |
53,028
-2,514
| -5% | -$67.7K |
|
1527
Littelfuse
LFUS
$9.91B
| $1.29M | ﹤0.01% |
14,177
-522
| -4% | -$47.5K |
|
|
FLTX
1528
DELISTED
Fleetmatics Group PLC
FLTX
| $1.29M | ﹤0.01% |
26,222
-1,107
| -4% | -$52.7K |
|
|
EFII
1529
DELISTED
Electronics for Imaging
EFII
| $1.29M | ﹤0.01% |
29,748
-805
| -3% | -$35.8K |
|
1530
First Financial Bankshares
FFIN
$5.05B
| $1.28M | ﹤0.01% |
80,594
-2,710
| -3% | -$44K |
|
1531
Cboe Global Markets
CBOE
$31.1B
| $1.27M | ﹤0.01% |
18,972
+6,449
| +51% | +$407K |
|
|
NE
1532
DELISTED
Noble Corporation
NE
| $1.27M | ﹤0.01% |
116,444
+52,025
| +81% | +$655K |
|
|
SP
1533
DELISTED
SP Plus Corporation
SP
| $1.27M | ﹤0.01% |
54,715
-318
| -0.6% | -$7.76K |
|
1534
Kite Realty
KRG
$5.91B
| $1.26M | ﹤0.01% |
53,134
-1,214
| -2% | -$30.3K |
|
1535
UMB Financial
UMBF
$10.9B
| $1.26M | ﹤0.01% |
24,884
-412
| -2% | -$21.7K |
|
1536
Belden
BDC
$4.09B
| $1.26M | ﹤0.01% |
27,000
-867
| -3% | -$51.1K |
|
1537
RPM International
RPM
$14.3B
| $1.26M | ﹤0.01% |
30,058
+10,096
| +51% | +$460K |
|
|
TVRD
1538
Tvardi Therapeutics
TVRD
$22.9M
| $1.26M | ﹤0.01% |
2,442
+159
| +7% | +$106K |
|
|
JNS
1539
DELISTED
Janus Capital Group Inc
JNS
| $1.25M | ﹤0.01% |
92,130
-229,320
| -71% | -$3.57M |
|
1540
Cousins Properties
CUZ
$5.22B
| $1.25M | ﹤0.01% |
48,090
-1,244
| -3% | -$34.3K |
|
1541
Lazard
LAZ
$4.21B
| $1.25M | ﹤0.01% |
28,914
+12,824
| +80% | +$661K |
|
|
BID
1542
DELISTED
Sotheby's
BID
| $1.25M | ﹤0.01% |
39,129
-1,557
| -4% | -$59.6K |
|
|
CMD
1543
DELISTED
Cantel Medical Corporation
CMD
| $1.25M | ﹤0.01% |
22,020
-840
| -4% | -$44.5K |
|
1544
Cytokinetics
CYTK
$10.8B
| $1.24M | ﹤0.01% |
185,783
+11,187
| +6% | +$76.4K |
|
|
ELLI
1545
DELISTED
Ellie Mae Inc
ELLI
| $1.24M | ﹤0.01% |
18,677
-2,356
| -11% | -$174K |
|
1546
Group 1 Automotive
GPI
$4.17B
| $1.24M | ﹤0.01% |
14,590
-262
| -2% | -$23.6K |
|
1547
Axos Financial
AX
$5.64B
| $1.24M | ﹤0.01% |
38,520
-924
| -2% | -$27.6K |
|
|
XHR
1548
Xenia Hotels & Resorts
XHR
$2.01B
| $1.24M | ﹤0.01% |
70,936
-2,181
| -3% | -$43.5K |
|
|
BGG
1549
DELISTED
Briggs & Stratton Corp.
BGG
| $1.24M | ﹤0.01% |
64,036
-1,172
| -2% | -$22.5K |
|
|
INXN
1550
DELISTED
Interxion Holding N.V.
INXN
| $1.23M | ﹤0.01% |
+45,400
| New | +$1.26M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.